ArticlePloS one2025
Sociodemographic predictors of acute corneal hydrops in patients with unstable keratoconus.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Factors influencing clinical research participation in ophthalmology: a mixed-methods study in keratoconus.Scientific reports · 2026Article
- Socioeconomic and Clinical Factors Associated with Keratoconus Severity and Follow-Up in a Tertiary Referral Cohort.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
Abstract
objectiveTo determine whether sociodemographic factors affect the outcomes of patients with unstable keratoconus.
designRetrospective case control study. SUBJECTS: All patients diagnosed with unstable keratoconus at Mass Eye and Ear between January 2016 and October 2022. Those who experienced acute corneal hydrops during the study period were considered cases, and those who did not were considered controls.
methodsPotential subjects were identified by billing code and verified with review of clinical documentation. Charts were reviewed for pertinent sociodemographic, medical, and ocular risk factors.
main outcome measuresClinical diagnosis of acute corneal hydrops was the primary outcome. Receipt of corneal crosslinking (CXL) was a secondary outcome.
resultsOf 762 patients diagnosed with unstable keratoconus, we identified 128 episodes of hydrops in 113 patients (14.9%). Compared to controls, cases were a significantly higher proportion Black (27.6% vs 14.6%, P < 0.0001), unemployed (22.4% vs 12.5%, P < 0.01), and/or covered by public health insurance plans (50.4% vs 27.7%, P < 0.0001). Body mass index (BMI) was significantly higher in cases (34.1 ± 10.0) than controls (29.2 ± 8.1, mean±SD, P < 0.0001). Developmental delay (17.7% vs 3.4%, P < 0.0001), atopy (48.9% vs 30.4%, P = 0.0001), sleep apnea (9.7% vs 1.2%, P < 0.0001), and eye rubbing (85.5% vs 67.7%, P < 0.01) were all more common in the hydrops group. In a stepwise multivariable logistic regression analysis, Black race [2.10 (1.02-4.27), P = 0.041], public health insurance coverage [2.06 (1.12-3.80), P = 0.020], BMI [1.05 (1.02-1.08), P = 0.003], and developmental delay [16.42 (5.62-56.30), P < 0.001] were each associated with a higher odds of incident hydrops [OR (95%CI)]. Similar trends were found to influence the receipt of CXL, with male sex [0.34 (0.13-0.77), P = 0.015], Black race [0.39 (0.16-0.97), P = 0.038], and public health insurance [0.37 (0.16-0.82), P = 0.014] negatively influencing the odds of receiving CXL.
conclusionsThis study establishes several sociodemographic (Black race, unemployment, and publicly insured) and medical (high BMI and developmental delay) factors as independent risk factors influencing the incidence of hydrops and/or the receipt of CXL in a large group of patients with unstable keratoconus. Special attention is warranted when caring for patients within these subpopulations with unstable keratoconus, and further study into the mechanisms of these associations is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.